Print
Email
Print Edition Stories
MHT's Galen Moore: Mass. companies building to be sold
MHT's Emerging Technologies Forum: Health IT and the Cloud
Global health diagnostics firm Daktari Diagnostics Inc. has landed $1.8 million in equity financing, according to a filing with the U.S. Securities and Exchange Commission. Among the investors are Mass Medical Angels, a seed-stage investing group focused on life science and healthcare investments.
The Cambridge-based company focuses on delivering diagnostic test results to doctors and patients. Its first product is an HIV point-of-care test that is designed to perform low-cost CD4 white blood cell counts to guide treatment. Daktari Diagnostics intends to bring the CD4 counter to global sites that have access to life-saving drugs but cannot begin or monitor treatment due to inadequate diagnostics.
In August 2009, Daktari Diagnostics closed a $2.8 million Series A round, led by the Partners Innovation Fund, with additional funding from angel investor groups Launchpad Venture Group, Hub Angels Investment Group and Boston Harbor Angels.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
